Chemistry:1cP-MiPLA

From HandWiki

1cP-MiPLA, also known as 1-cyclopropanoyl-MiPLA or 1-cyclopropanoyl-N-methyl-N-isopropyllysergamide, is a presumed psychedelic drug of the lysergamide family.[1][2][3] It is the 1-cyclopropanoyl derivative of MiPLA (N-methyl-N-isopropyllysergamide) and is thought to be a prodrug of MiPLA.[1][2][3] 1cP-MiPLA has been encountered as a novel designer drug online[1] and in Japan.[2][3]

Use and effects

1cP-MiPLA has been sold in the form of blotter tabs containing doses of 200 μg per tab.[1] Data on the effects of 1cP-MiPLA at different doses are not available.[1]

Interactions

Pharmacology

1cP-MiPLA is assumed to act as a prodrug of MiPLA via deacylation.[2][3] Relatedly, it is assumed to act as a serotonin receptor agonist, including of the serotonin 5-HT2A receptor, and to be a serotonergic psychedelic.[1]

Chemistry

Analogues

Analogues of 1cP-MiPLA include MiPLA, 1P-MiPLA, and 1cP-AL-LAD, among others.

History

1cP-MiPLA was first encountered as a novel designer drug online in 2020[1] and in Japan by 2022.[2][3]

Society and culture

Canada

1cP-MiPLA is not a controlled substance in Canada as of 2025.[4]

Russia

1cP-MiPLA is a schedule I controlled substance in Russia.[1]

United States

1cP-MiPLA is not an explicitly controlled substance in the United States.[5] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.

See also

References